ARID2 expression significantly decreased in metastatic HCC tissues, showing a negative correlation with pathological grade and organ metastasis, and a positive association with survival of HCC patients (Jiang et al., 2020). This evidence concerns the gene ARID2 and hepatocellular carcinoma.